Lv4
716 积分 2024-06-05 加入
Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
mRNA lipid nanoparticles in CAR-T therapy: a novel strategy to improve efficacy
1个月前
已完结
Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
2个月前
已完结
Controlled release and antioxidant activity of chitosan and β-lactoglobulin complex nanoparticles loaded with epigallocatechin gallate
2个月前
已完结
In vivo engineered quadrivalent CAR-macrophages break tumor barrier,remodel TME and overcome tumor heterogeneity through antigen spreading
4个月前
已完结
Abstract 1321: In vivo immune cell programming using mRNA-LNP chimeric antigen receptors
4个月前
已关闭
Synergically enhanced anti-tumor immunity of in vivo panCAR by circRNA vaccine boosting
4个月前
已完结
Critical Considerations of mRNA-LNPs Technology for CAR-T Therapy: Components, Payloads and Emerging Horizons
5个月前
已完结
Peptide codes for organ-selective mRNA delivery
5个月前
已完结
皖公网安备34019202002308
